thread: All rotavirus vaccines contaminated worldwide - FDA suspends its use

Hybrid View

Previous Post Previous Post   Next Post Next Post
  1. #1
    ♥ BellyBelly's Creator ♥
    Add BellyBelly on Facebook Follow BellyBelly On Twitter

    Feb 2003
    Melbourne, Victoria, Australia, Australia
    8,982

    All rotavirus vaccines contaminated worldwide - FDA suspends its use

    And people think those of us who don't support such vaccinations are taking risks.... here's why we think like we do. The things we do and say are safe today, may not be tomorrow, especially when these things are pushed out to market without adequate long-term testing, in order to get the $$. This is rife in this industry, as in obstetrics...

    Hamburg said the pig virus DNA fragments have been found in Glaxo's cell bank, meaning they were present from the vaccine's earliest development. How the original contamination occurred is under investigation.
    FDA Suspends Use of GlaxoSmithKline Rotavirus Vaccine Tainted with Pig Virus - AGE OF AUTISM

    March 22, 2010

    FDA Suspends Use of GlaxoSmithKline Rotavirus Vaccine Tainted with Pig Virus

    The FDA has recomended the temporary suspension of GlaxoSmithKline's rotavirus vaccine called Rotarix, which is a direct competitor of Dr. Paul Offit's RotaTeq vaccine from Merck. AP medical news reported an "apparently benign pig virus" as the contaminant. Fortunately for patient safety, AP Medical News reported "A group of scientists testing a new way to detect viruses in a variety of products stumbled onto fragments of genetic material — broken pieces of DNA — from what's called porcine circovirus-1 in Rotarix and alerted Glaxo, which confirmed the findings and in turn alerted FDA, Hamburg said." The report stressed that the suspension of use has been recommended despite no evidence of harm.

    From the FDA: On Monday, March 22, the Food and Drug Administration recommended that clinicians and public health professionals in the United States temporarily suspend the use of Rotarix, a rotavirus vaccine produced by GlaxoSmithKline.

    FDA has learned that components of an extraneous virus are present in Rotarix. There is no evidence at this time that this finding poses a safety risk. However, the FDA asks that clinicians temporarily suspend use of the vaccine while the agency learns more about the situation. More information is available at: HERE.

    From AP Medical News via Yahoo: WASHINGTON – U.S. health officials told pediatricians Monday to temporarily quit using one of two vaccines against a leading cause of diarrhea in babies, after discovering that doses of GlaxoSmithKline's Rotarix were contaminated with bits of an apparently benign pig virus.

    Glaxo's vaccine has been used in millions of children worldwide, including 1 million in the U.S., with no signs of safety problems — and the pig virus isn't known to cause any kind of illness in people or animals, said Dr. Margaret Hamburg, commissioner of the Food and Drug Administration.

    But vaccines are supposed to be sterile, and because there is a competing vaccine against diarrhea-causing rotavirus that has tested clean — Merck's RotaTeq — the FDA decided to err on the side of caution.

    "We don't want to scare parents," Hamburg told reporters. "This was a difficult decision for us to make because there is no evidence at this time that there is a risk to patients who have received this vaccine, and we know there are real benefits for children to be vaccinated against rotavirus."

    Rotavirus causes severe diarrhea and is a leading child killer in developing countries. In the U.S., with better health care, about 55,000 children a year were hospitalized for rotavirus infections and several dozen died each year before vaccination began — with Merck's vaccine in 2006 and Glaxo's in 2008.

    Glaxo said Monday that regulators abroad have decided not to change how Rotarix is used while scientists probe the relevance of the discovery.

    A group of scientists testing a new way to detect viruses in a variety of products stumbled onto fragments of genetic material — broken pieces of DNA — from what's called porcine circovirus-1 in Rotarix and alerted Glaxo, which confirmed the findings and in turn alerted FDA, Hamburg said.

    Rotarix, an oral vaccine, is made from a weakened strain of human rotavirus that has to be grown inside living cells before being purified into a vaccine dose. Glaxo uses a line of monkey kidney cells, or vero cells. Hamburg said the pig virus DNA fragments have been found in Glaxo's cell bank, meaning they were present from the vaccine's earliest development. How the original contamination occurred is under investigation.

    Merck's competing rotavirus vaccine RotaTeq is made by a very different process, and FDA's testing showed no sign of the pig virus in it.

    It's not the first time unwanted viruses have been discovered in vaccines. Best known is a monkey virus that contaminated some polio vaccine in the 1950s; years later, scientists investigated if the SV40 virus might have increased vaccine recipients' risk of later-in-life cancer but concluded it didn't.

    "We live in a world that's teeming with microbes," Hamburg said, but until now this particular pig virus is not one that FDA thought vaccine makers needed to check their products against.

    Parents should switch to the Merck vaccine for now — it requires three doses instead of Glaxo's two — because rotavirus is too serious a disease to ignore, said Dr. William Schaffner, a vaccine specialist at Vanderbilt University who was briefed on FDA's decision.

    He's bracing for calls from worried parents and will tell them that "this has been an extraordinarily safe vaccine," and that the discovery is "a consequence of our improved science and ability to detect things that we never could before."
    Kelly xx

    Creator of BellyBelly.com.au, doula, writer and mother of three amazing children
    Author of Want To Be A Doula? Everything You Need To Know
    In 2015 I went Around The World + Kids!
    Forever grateful to my incredible Mod Team

  2. #2
    Registered User

    Jan 2008
    3,305

    what ages do kids get this?

  3. #3

    Oct 2005
    A Nestle Free Zone... What about YOU?
    5,374

    Thanks Kelly it's bloody frightening and yes the reason why there is such fear about vaccination. Because it seems this happens all too frequently. Thankyou for sharing this info...

  4. #4
    Registered User

    Apr 2009
    in the garden
    3,767

    what ages do kids get this?
    The schedule in DD's book is for 2, 4 & 6mths.

    I would take this to mean that they are given the Merck vaccine (3 does instead of 2).

    Deosn't make me feel a lot better about it though although DD has had hers, too late now.

    Thanks for sharing Kelly, I wish this info was more 'out there'.

  5. #5
    Registered User

    Jan 2009
    pakenham, victoria
    3,660

    have just printed this off to hand to MCHN when she gives me the 3rd degree about our decision to not vaccinate again! thanks Kelly

  6. #6
    Registered User

    Oct 2007
    Sunshine Coast
    746

    Yes the RotaTeq is 3 doses and this is the one on the schedule.

    Before it was on the schedule it was an optional extra vax that you had to pay for yourself at the GP and then claim back, which is what I did for DS. Some GPs had RotaTeq, others had Rotarix, which was only 2 doses.

    I am, generally speaking, pro-vax, but I can't deny that I am feeling a little like I've dodged a bullet on this one and only because my own GP had done their due diligence, decided that RotaTeq was the better vaccine and chose to administer it over the Rotarix.

  7. #7
    BellyBelly Member

    Dec 2005
    3,130

    ok, i admit i only skimmed that.. but didnt it say although it showed up there was the virus in there it hasnt harmed anyone?

  8. #8
    Registered User

    Feb 2010
    Travelling
    666

    Re: All rotavirus vaccines contaminated worldwide - FDA suspends its use

    So can I just check I have it right as DD is having her 6 month jabs this week...

    It's the one that's given in 2 doses that there's been the problem with?

    Also, as I've seen it come up here as well as in several other threads, what is the reason behind those who chose to vax opting to decline the cp vax? And where do you all get your info from to decide whether to vax or not? I've decided not to get swine flu vaccine for DD based on easily accessible info, but where can I read up on others in more depth?

  9. #9
    Lucy in the sky with diamonds.

    Jan 2005
    Funky Town, Vic
    7,070

    check the vacc info threads, there are several thread in which members give their reasoning.

  10. #10
    ♥ BellyBelly's Creator ♥
    Add BellyBelly on Facebook Follow BellyBelly On Twitter

    Feb 2003
    Melbourne, Victoria, Australia, Australia
    8,982

    Kelly xx

    Creator of BellyBelly.com.au, doula, writer and mother of three amazing children
    Author of Want To Be A Doula? Everything You Need To Know
    In 2015 I went Around The World + Kids!
    Forever grateful to my incredible Mod Team

  11. #11
    ♥ BellyBelly's Creator ♥
    Add BellyBelly on Facebook Follow BellyBelly On Twitter

    Feb 2003
    Melbourne, Victoria, Australia, Australia
    8,982

    With the Chicken Pox vaccination they have found it to be too ineffective and are currently talking of introducing an additional shot to make it work better. Of all the kids at my son's kinder last year, those who were vaccinated were the ones who got it.
    Kelly xx

    Creator of BellyBelly.com.au, doula, writer and mother of three amazing children
    Author of Want To Be A Doula? Everything You Need To Know
    In 2015 I went Around The World + Kids!
    Forever grateful to my incredible Mod Team

  12. #12
    Registered User

    Apr 2009
    Out on the sauce with the Tombliboos!
    206

    Statement on Rotarix® (Rotavirus vaccine)

    From the Australian Therapeutic Goods Adminsitration; The FDA is a US Government Agency and has no say whasoever on what happens with drugs, medications and therpeteutic goods in this country. Its important when discussing topics as important as this to use the accredited sources. The FDA hasn't suspended the use of Rotarix only asked Drs to withold it's administration until further investigations are complete. http://www.tga.gov.au/alerts/medicines/rotarix.htm

    24 March 2010
    On 17 March 2010 GlaxoSmithKline (GSK) notified the Therapeutic Goods Administration (TGA) and other regulatory agencies around the world of a manufacturing quality issue concerning its rotavirus vaccine Rotarix.
    The company advised the TGA that DNA fragments of a virus identified as porcine circovirus type 1 (PCV1), had been found in batches of the product. PCV1 is common in pigs but does not cause illness in pigs or any other animals, nor has it been shown to cause illness or replicate in humans. The risk of any illness from ingesting such material is remote.
    Two oral vaccines (Rotarix and RotaTeq) are currently approved for use in Australia and included in the National Immunisation Program (NIP) for babies aged 2 to 6 months of age for the prevention of rotavirus, a form of gastroenteritis which can be severe. Rotarix was added to the NIP in 2007.
    The TGA is working closely with other regulatory agencies overseas and the company, GSK, to obtain information and expert advice to ensure that the vaccine is safe and effective. In addition, the TGA is convening an expert panel to provide further advice on the matter.
    The European Medicines Agency (EMA) has taken no regulatory action, but is continuing to gather information pending a meeting of its Committee for Human Medical Products Vaccine Working Group scheduled for 24 March 2010.
    The US FDA has not taken any regulatory action, but has requested US medical practitioners not to use Rotarix for the next 4 to 6 weeks while the matter is further investigated.
    Clinical trials data and extensive experience to date have demonstrated that Rotarix is effective in preventing infection with rotavirus and is well tolerated in babies. Individual vaccination programs that have commenced should continue, and parents should contact their doctor if they have concerns about immunisation of their baby with Rotarix.
    The TGA will provide additional advice regarding its careful scientific risk assessment as soon as it is completed. Based on current evidence and pending further expert review the TGA does not consider this constitutes a threat to public health.
    A comprehensive list of Frequently Asked Questions follows.

    Frequently asked questions

    What is rotavirus?

    Rotavirus is named after its characteristic wheel-like appearance when viewed under an electron microscope. Rotavirus is the leading cause of severe diarrhoea and dehydration in young infants worldwide. It is estimated to be responsible for the deaths of more than 500,000 infants around the world each year, primarily in low- and middle-income countries.
    In Australia, prior to the introduction of rotavirus vaccination, it was estimated that there were approximately 10,000 hospitalisations due to rotavirus in children less than 5 years of age each year. In addition to hospitalised children, an estimated 5,000 children under 5 years of age visited a GP, and 22,000 children required an emergency department visit due to rotavirus illness each year. On average, there was one death due to rotavirus each year in Australia.

    What are the symptoms of rotavirus infection?


    Rotavirus infects the intestines. The disease usually starts with fever, an upset stomach, and vomiting, followed by diarrhoea. The disease generally lasts 3-8 days.

    How is rotavirus infection treated?

    There is no specific treatment for the rotavirus infection. The most serious problem caused by the disease is dehydration, so symptoms are treated mostly by oral rehydration. Severe cases require administration of intravenous fluids in a hospital. Rotavirus disease can be prevented with vaccination.

    How does rotavirus spread?

    Rotavirus is usually spread when children touch or place in their mouths small, usually invisible amounts of faecal matter found on surfaces such as toys, books and clothing, or on the hands of caregivers. The virus can also be transmitted through contaminated water or food, and possibly by respiratory droplets in a sneeze, cough, or exhalation. The virus is very contagious. Nearly all children are exposed to rotavirus at some point before the age of 5 years.

    Rotavirus vaccines

    After evaluating data from extensive clinical and non-clinical tests, TGA registered GlaxoSmithKline's Rotarix vaccine in March 2006. A second rotavirus vaccine RotaTeq is also marketed in Australia by Merck, Sharp & Dohme (Australia) Pty Ltd. TGA registered RotaTeq in May 2006. Pre- and post-market studies have shown both vaccines to be highly effective at preventing serious gastrointestinal disease caused by rotavirus. No serious or unexpected safety concerns have been identified in postmarket surveillance of either vaccine.

    What is Rotarix?

    Rotarix is a live-attenuated human rotavirus vaccine. It causes a slight infection that typically produces no symptoms, but creates immunity against rotavirus.
    Rotarix is available in Australia as an oral liquid suspension and is administered by mouth in a two-dose schedule on the National Immunisation Program between six and fourteen weeks of age. The first dose can be given beginning at six weeks of age and the second at least four weeks after the first dose, but before the child reaches 24 weeks of age.


    What countries currently use Rotarix?

    In addition to Australia, Rotarix is licensed in the United States, the European Union and nearly 100 other countries.

    How many doses of Rotarix have been sold?

    Current data indicate that between July and December 2009, 91331 doses of Rotarix were used in Australia. Rotarix is predominantly used in NSW, ACT, NT and Tasmania. It was previously used in WA during 2007 to 2009. To date it is estimated that 68 million doses of the vaccine have been distributed worldwide, and more than 70000 children have participated in clinical trials. No unexpected pattern of adverse reactions to the vaccine has been reported in any country.

    What other rotavirus vaccines are currently available?

    The other licensed rotavirus vaccine is Merck, Sharp & Dohme's RotaTeq, also a live-attenuated viral vaccine taken by mouth. It was tested in more than 70,000 children, primarily in the United States and Finland, and registered in Australia in May 2006. The vaccination is administered in a three dose schedule starting at 6 to 12 weeks of age, with the subsequent doses administered at 4- to 10-week intervals; the third dose should be given by 32 weeks of age. During the period July and December 2009, more than 304,000 doses of RotaTeq were administered in Australia. RotaTeq is currently used in Victoria, Queensland, SA and WA.

    Background on PCV1
    Porcine circovirus 1 (PCV1) is a small, circular virus composed of a single strand of DNA that is very common in pigs but is not known to cause disease in animals or humans. It was first identified in 1974. PCV1 may be acquired from eating pork and from exposure to farm animals. It has not been shown to cause disease in pigs, humans or any other animals. PCV1 is found in many meat products.
    PCV1 should not be confused with PCV2. PCV2 is a circovirus that causes illness in pigs, but not humans.


    Is PCV1 a pig material?

    No. PCV1 is a virus. It is not animal material.
    Detection of DNA from PCV1 in Rotarix
    The presence of components of PCV1 in Rotarix was discovered when an independent US academic research team applied a new technology for detecting viral genetic material. The researchers detected DNA fragments of PCV1 in two lots of Rotarix vaccine.

    The researchers notified GlaxoSmithKline of their findings on 9 February 2010. The company then initiated extensive experiments to confirm the results and undertake further investigations. These included a series of assessments on the same two lots of the finished vaccine, as well as on vaccine materials at different stages of the production process.
    These follow-up tests confirmed the presence of many copies of DNA from PCV1 in the two finished vaccine lots that had previously been tested, as well as in intermediates in the production process, and in the working cell bank and viral "seed" from which the vaccine was derived.
    The firm notified TGA of its findings on 17 March 2010. TGA staff then began to review the evidence, consult with experts, contact other public health officials in Australia, and communicate with international regulatory counterparts.


    Has DNA from PCV1 been found in other lots of Rotarix?

    In its follow-up assessments, GlaxoSmithKline detected the presence of DNA from PCV1 in the working cell bank and viral "seed" used to produce Rotarix, confirming that the material has been present since the early stages of product development, including during clinical studies.

    Why wasn't the presence of DNA from PCV1 detected in previous reviews of Rotarix?
    Circoviruses such as PCV1 have not been associated with illnesses in humans, and the identification of DNA fragments by the academic researchers has only recently become possible due to technological developments. No regulatory agency has required testing for the presence of the virus or any components as this has not been possible previously.

    How did DNA from PCV1 come to be present in Rotarix?
    At this time, TGA does not know how DNA from PCV1 came to be present in Rotarix. TGA, other regulatory agencies and GlaxoSmithKline are investigating this issue as a matter of urgency.

    Does the detection of DNA from PCV1 indicate that the virus is present in Rotarix?
    Although DNA fragments from PCV1 have been detected in Rotarix, it is not yet known whether this means that intact virus is present. Additional studies are currently being conducted to establish whether or not intact PCV1 is present in Rotarix.

    Does the detection of DNA from PCV1 in Rotarix raise special concerns for influenza vaccines?
    No. The manufacturing process for Rotarix is very different from the manufacturing process for influenza vaccines. Unlike Rotarix, a cell-based vaccine, the influenza vaccines currently on the market are egg-based vaccines. The cell-based influenza vaccine currently in development uses materials that are different from the one used to develop Rotarix.

    TGA actions
    After learning of the detection of PCV1 DNA in Rotarix on 17 March 2010, TGA began reviewing the available evidence, and consulting with relevant clinical and scientific experts, conferring with public health officials, and exchanging information with regulatory counterparts in other countries to establish a better understanding of the extent, if any, of possible risk. The TGA has urgently requested further and complete information from the manufacturer, GSK.
    In the United States, the FDA also tested lots of RotaTeq for evidence of PCV1. The agency’s preliminary studies have not found DNA from PCV1 in Rotateq.


    Are follow-up assessments being conducted?
    The TGA's investigations are ongoing. Both TGA and GlaxoSmithKline are reviewing all available evidence and additional tests are being conducted to obtain more information about the presence of PCV1 DNA in Rotarix, including whether intact virus (as opposed to DNA fragments) is present.

    Information for parents and caregivers
    Rotavirus causes severe diarrhoea and dehydration in young infants. There are two licensed vaccines for rotavirus in Australia: RotaTeq and Rotarix. Each of these vaccines is given by mouth in a series of doses during the first year of life.

    My child has received or is due to receive the Rotarix vaccine. Should I be worried?
    All available evidence, including clinical studies involving tens of thousands of children, supports the safety of the vaccine. PCV1 is not known to cause disease in humans. Children who received Rotarix need no additional medical follow-up. Scheduled vaccination with Rotarix should proceed as normal.
    Information for healthcare providers and public health professionals

    Is there any medical follow-up needed for children who have received the Rotarix vaccine?
    No. The risk of any illness from ingesting any such material is unlikely. TGA does not believe special medical follow-up is warranted for children who have been vaccinated with Rotarix. Extensive pre- and post-market clinical studies involving tens of thousands of vaccine recipients support the safety and effectiveness of the vaccine.
    If a child has received one dose of Rotarix, what should I do for the next dose?
    For children who have received one dose of Rotarix, it is recommended that the vaccination course be completed according to the usual timetable for the second dose.
    Last edited by Visitor6; March 25th, 2010 at 01:53 PM.

  13. #13
    Registered User
    Add Little Chicken on Facebook

    Mar 2010
    Melbourne
    1,855

    So can I just check I have it right as DD is having her 6 month jabs this week...

    It's the one that's given in 2 doses that there's been the problem with?

    Also, as I've seen it come up here as well as in several other threads, what is the reason behind those who chose to vax opting to decline the cp vax? And where do you all get your info from to decide whether to vax or not? I've decided not to get swine flu vaccine for DD based on easily accessible info, but where can I read up on others in more depth?
    try looking up these information sheets (hopefully I can post the link), they are the best I have seen.

    NCIRS fact sheets - NCIRS - National Centre for Immunisation Research and Surveillance